Related Experiment Video
Updated: Apr 18, 2026
06:31
Primary Tumor and MEF Cell Isolation to Study Lung Metastasis
Published on: May 20, 2015
16.7K
Lung adenocarcinomas: comparison between mice and men.
1Institute of Pathology, Research Unit Molecular Lung & Pleura Pathology, Medical University of Graz, Auenbruggerplatz 25, 8036, Graz, Austria, helmut.popper@medunigraz.at.
Methods in Molecular Biology (Clifton, N.J.)
|February 1, 2015
Summary
Mouse models for human cancers, especially lung cancer, are crucial. This review compares the morphology of mouse and human non-small cell lung cancer, highlighting discrepancies and the need for better genetic models.
Area of Science:
- Oncology
- Comparative Pathology
- Translational Research
Background:
- Developing accurate animal models for human cancers is essential for research.
- Existing mouse models often neglect the morphological similarities crucial for effective translation.
- Comparative histopathology between human and mouse tumors is lacking, hindering model validation.
Purpose of the Study:
- To review and compare the species-specific and common morphological features of non-small cell lung cancer (NSCLC) in mice and humans.
- To identify inconsistencies in current mouse models of NSCLC.
- To discuss the implications for developing improved genetic tools for cancer modeling.
Main Methods:
- Comparative analysis of histopathological features of human and mouse non-small cell lung cancer.
- Review of existing literature on genetic and chemical mouse models of lung cancer.
- Discussion of morphological similarities and differences between species.
Main Results:
- Significant morphological differences exist between human and mouse non-small cell lung cancer, despite genetic manipulations.
- Commonly used RAS-induced mouse lung tumors show inconsistencies when compared to human lung cancer subtypes.
- Current models may not fully recapitulate the diverse morphologic spectrum of human lung malignancies.
Conclusions:
- Accurate morphological recapitulation is critical for the translational validity of mouse cancer models.
- Refined genetic tools and rigorous comparative histopathology are needed to improve mouse models of non-small cell lung cancer.
- Addressing morphological discrepancies will enhance the utility of mouse models in understanding human lung cancer progression and developing therapies.
